3 results
Approved WMOCompleted
The aim of this study is to assess the safety and tolerability of oral administration of simvastatin plus rifaximin in patients with decompensated cirrhosis.
Approved WMORecruiting
To assess safety and tolerability of AMX0035 for treatment of ALS.
Approved WMOCompleted
The aim of this study is to assess the efficacy of oral administration of simvastatin plus rifaximin in patients with decompensated cirrhosis to halt the progression of the disease as assessed by prevention of the development of ACLF.